Assembly Biosciences (ASMB) Upgraded to Strong Buy: Here's Why

This article was originally published on Nasdaq

Assembly Biosciences (ASMB) could be a solid choice for investors given its recent upgrade to a Zacks Rank #1 (Strong Buy). This rating change essentially reflects an upward trend in earnings estimates — one of the most powerful forces impacting stock prices.

Responses